[1] Xu, L, et al(2013). Pharmacokinetics of Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration: A Population Approach[J].Investigative Ophthalmology & Visual Science, 54(3): 1616~1624. [2] Li, X, et al(2014). Safety and Efficacy of Conbercept in Neovascular Age-Related Macular Degeneration: Results from a 12-Month Randomized Phase 2 Study[J].AURORA Study." Ophthalmology. [3] 韩敏,张爱琴.不溶性微粒分析在临床注射剂质量控制中的应用[J].中国药学杂志,2006,41(24):1917~1918. |